medigraphic.com
Instituto Nacional de Salud Pública

2020, Number 1

Next >>

salud publica mex 2020; 62 (1)

The control of diarrhea, the case of a rotavirus vaccine

Parashar UD, Tate JE

Language: English
References: 58
Page: 1-5
PDF size: 248.02 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Davidson GP, Bishop RF, Townley RR, Holmes IH. Importance of a new virus in acute sporadic enteritis in children. Lancet. 1975;305(7901):242-6. https://doi.org/10.1016/S0140-6736(75)91140-X

  2. Agocs MM, Serhan F, Yen C, Mwenda JM, de Oliveira LH, Teleb N, et al. WHO global rotavirus surveillance network: a strategic review of the first 5 years, 2008-2012. MMWR Morb Mortal Wkly Rep. 2014;63(29):634-7.

  3. Tate JE, Burton AH, Boschi-Pinto C, Parashar UD, World Health Organization-Coordinated Global Rotavirus Surveillance Network. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000-2013. Clin Infect Dis. 2016;62(suppl 2):S96-105. https://doi. org/10.1093/cid/civ1013

  4. Lanata CF, Fischer-Walker CL, Olascoaga AC, Torres CX, Aryee MJ, Black RE, Child Health Epidemiology Reference Group of the World Health Organization and UNICEF. Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS One. 2013;8(9):e72788. https://doi.org/10.1371/journal.pone.0072788

  5. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71. https://doi. org/10.1016/S0140-6736(14)61682-2

  6. Villa S, Guiscafre H, Martinez H, Munoz O, Gutierrez G. Seasonal diarrhoeal mortality among Mexican children. Bull World Health Organ. 1999;77(5):375-80.

  7. Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter- Campbell S, et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996;335(14):1022-8. https://doi. org/10.1056/NEJM199610033351404

  8. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine--United States, 1998-1999. MMWR Morb Mortal Wkly Rep. 1999;48(27):577-81.

  9. Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344(8):564-72. https://doi.org/10.1056/ NEJM200102223440804

  10. Peter G, Myers MG, National Vaccine Advisory C, National Vaccine Program O. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics. 2002; 110(6):e67. https://doi.org/10.1542/ peds.110.6.e67

  11. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354(1):23-33. https://doi. org/10.1056/NEJMoa052664

  12. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11-22. https:// doi.org/10.1056/NEJMoa052434

  13. Conclusions and recommendations from the Immunization Strategic Advisory Group. Wkly Epidemiol Rec. 2006;81(1):2-11.

  14. World Health Organization. Rotavirus vaccines:an update. Wkly Epidemiol Rec. 2009;84(50):533-40.

  15. International Vaccine Access Center. Current Vaccine Intro status. Bloomberg School of Public Health, 2018 [cited 2019]. Available from: www.view-hub.org/viz/

  16. Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD. Effectiveness of rotavirus vaccination: A systematic review of the first decade of global postlicensure data, 2006-2016. Clin Infect Dis. 2017;65(5):840-50. https:// doi.org/10.1093/cid/cix369

  17. Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J Infect Dis. 2017;215(11):1666-72. https://doi.org/10.1093/infdis/ jix186

  18. Gurgel RQ, Ilozue C, Correia JB, Centenari C, Oliveira SM, Cuevas LE. Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil. Trop Med Int Health. 2011;16(9):1180-4. https://doi. org/10.1111/j.1365-3156.2011.02844.x

  19. Lanzieri TM, Linhares AC, Costa I, Kolhe DA, Cunha MH, Ortega-Barria E, Colindres RE. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. Int J Infect Dis. 2011;15(3):e206-10. https://doi. org/10.1016/j.ijid.2010.11.007

  20. Sanchez-Uribe E, Esparza-Aguilar M, Parashar UD, Richardson V. Sustained reduction of childhood diarrhea-related mortality and hospitalizations in Mexico after rotavirus vaccine universalization. Clin Infect Dis. 2016;62(suppl 2): S133-9. https://doi.org/10.1093/cid/civ1205

  21. Gastanaduy PA, Sanchez-Uribe E, Esparza-Aguilar M, Desai R, Parashar UD, Patel M, Richardson V. Effect of rotavirus vaccine on diarrhea mortality in different socioeconomic regions of Mexico. Pediatrics. 2013;131(4):e1115-20. https://doi.org/10.1542/peds.2012-2797

  22. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza- Aguilar M, Johnson B, Gomez-Altamirano CM, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362(4):299-305. https://doi.org/10.1056/NEJMoa0905211

  23. do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med. 2011;8(4):e1001024. https://doi.org/10.1371/journal. pmed.1001024

  24. Inchauste L, Patzi M, Halvorsen K, Solano S, Montesano R, Iniguez V. Impact of rotavirus vaccination on child mortality, morbidity, and rotavirusrelated hospitalizations in Bolivia. Int J Infect Dis. 2017;61:79-88. https:// doi.org/10.1016/j.ijid.2017.06.006

  25. Bayard V, DeAntonio R, Contreras R, Tinajero O, Castrejon MM, Ortega-Barría E, Colindres RE. Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama. Int J Infect Dis. 2012;16(2):e94-8. https://doi.org/10.1016/j.ijid.2011.09.003

  26. Gastanaduy PA, Curns AT, Parashar UD, Lopman BA. Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination. JAMA. 2013;310(8):851-3. https://doi.org/10.1001/jama.2013.170800

  27. Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis. 2011;204(7):980-6. https://doi.org/10.1093/infdis/jir492

  28. Burke RM, Tate JE, Dahl RM, Aliabadi N, Parashar UD. Rotavirus vaccination is associated with reduced seizure hospitalization risk among commercially insured US children. Clin Infect Dis. 2018;67(10):1614-6. https://doi.org/10.1093/cid/ciy424

  29. Pringle KD, Burke RM, Steiner CA, Parashar UD, Tate JE. Trends in rate of seizure-associated hospitalizations among children <5 years old before and after rotavirus vaccine introduction in the United Sates, 2000-2013. J Infect Dis. 2018;217(4):581-8. https://doi.org/10.1093/infdis/jix589

  30. Payne DC, Baggs J, Zerr DM, Klein NP, Yih K, Glanz J, et al. Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis. 2014;58(2):173-7. https://doi.org/10.1093/cid/cit671

  31. Pardo-Seco J, Cebey-Lopez M, Martinon-Torres N, Salas A, Gómez-Rial J, Rodriguez-Tenreiro C, et al. Impact of rotavirus vaccination on childhood hospitalization for seizures. Pediatr Infect Dis J. 2015;34(7):769-73. https:// doi.org/10.1097/INF.0000000000000723

  32. Chitambar SD, Tatte VS, Dhongde R, Kalrao V. High frequency of rotavirus viremia in children with acute gastroenteritis: discordance of strains detected in stool and sera. J Med Virol. 2008;80(12):2169-76. https://doi. org/10.1002/jmv.21338

  33. Lloyd MB, Lloyd JC, Gesteland PH, Bale JF Jr. Rotavirus gastroenteritis and seizures in young children. Pediatr Neurol. 2010;42(6):404-8. https:// doi.org/10.1016/j.pediatrneurol.2010.03.002

  34. Lynch M, Lee B, Azimi P, Gentsch J, Glaser C, Gilliam S, et al. Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review. Clin Infect Dis. 2001;33(7):932-8. https://doi. org/10.1086/322650

  35. Isik U, Caliskan M. Reversible EEG changes during rotavirus gastroenteritis. Brain Dev. 2008;30(1):73-6. https://doi.org/10.1016/j.braindev. 2007.05.006

  36. Iyadurai S, Troester M, Harmala J, Bodensteiner J. Benign afebrile seizures in acute gastroenteritis: is rotavirus the culprit? J Child Neurol. 2007;22(7):887-90. https://doi.org/10.1177/0883073807304703

  37. John TJ. Antibody response of infants in tropics to five doses of oral polio vaccine. Br Med J. 1976;1(6013):812. https://doi.org/10.1136/ bmj.1.6013.812

  38. John TJ, Jayabal P. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am J Epidemiol. 1972;96(4):263-9. https://doi.org/10.1093/oxfordjournals.aje. a121457

  39. Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis. 1991;13(5):926-39. https://doi.org/10.1093/clinids/13.5.926

  40. Suharyono, Simanjuntak C, Witham N, Punjabi N, Heppner DG, Losonsky G, et al. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet. 1992;340(8821):689-94. https://doi.org/10.1016/0140-6736(92)92231-4

  41. Gotuzzo E, Butron B, Seas C, Penny M, Ruiz R, Losonsky G, et al. Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels. Infect Immun. 1993;61(9):3994-7.

  42. Ali A, Kazi AM, Cortese MM, Fleming JA, Moon S, Parashar UD, et al. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial. PLoS One. 2015;10(6):e0127622. https://doi.org/10.1371/journal.pone.0127622

  43. Groome MJ, Moon SS, Velasquez D, Jones S, Koen A, van Niekerk N, et al. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ 2014;92(4):238-45. https:// doi.org/10.2471/BLT.13.128066

  44. Armah G, Lewis KD, Cortese MM, Parashar UD, Ansah A, Gazley L, et al. A randomized, controlled trial of the impact of alternative dosing schedules on the immune response to human rotavirus vaccine in rural Ghanaian infants. J Infect Dis. 2016;213(11):1678-85. https://doi. org/10.1093/infdis/jiw023

  45. Zaman K, Fleming JA, Victor JC, Yunus M, Bari TI, Azim T, et al. Noninterference of rotavirus vaccine with measles-rubella vaccine at 9 months of age and improvements in antirotavirus immunity: A randomized trial. J Infect Dis. 2016;213(11):1686-93. https://doi.org/10.1093/infdis/jiw024

  46. Lazarus RP, John J, Shanmugasundaram E, Rajan AK, Thiagarajan S, Giri S, et al. The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants. Vaccine. 2018;36(2):273-9. https://doi.org/10.1016/j.vaccine.2017.07.116

  47. Kirkwood CD, Ma LF, Carey ME, Steele AD. The rotavirus vaccine development pipeline. Vaccine. 2017;pii:S0264-410X(17)30410-3. https:// doi.org/10.1016/j.vaccine.2017.03.076

  48. Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014;370(6):513-9. https://doi.org/10.1056/NEJMoa1311738

  49. Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, et al. Intussusception risk after rotavirus vaccination in US infants. N Engl J Med. 2014;370(6):503-12. https://doi.org/10.1056/NEJMoa1303164

  50. Stowe J, Andrews N, Ladhani S, Miller E. The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation. Vaccine. 2016;34(32):3684-9. https://doi. org/10.1016/j.vaccine.2016.04.050

  51. Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia’s National Immunization Program. Clin Infect Dis. 2013;57(10):1427-34. https://doi.org/10.1093/cid/cit520

  52. Yung CF, Chan SP, Soh S, Tan A, Thoon KC. Intussusception and monovalent rotavirus vaccination in Singapore: Self-controlled case series and risk-benefit study. J Pediatr. 2015;167(1):163-8 e1. https://doi.org/10.1016/j. jpeds.2015.03.038

  53. Richardson V, Parashar U, Patel M. Childhood diarrhea deaths after rotavirus vaccination in Mexico. N Engl J Med. 2011;365(8):772-3. https:// doi.org/10.1056/NEJMc1100062

  54. Tate JE, Mwenda JM, Armah G, Jani B, Omore R, Ademe A, et al. Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa. N Engl J Med. 2018;378(16): 1521-8. https://doi.org/10.1056/NEJMoa1713909

  55. Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life. Vaccine. 2014;32(suppl 1):A110-6. https://doi.org/10.1016/j.vaccine.2014.04.079

  56. Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9935):2136-43. https://doi.org/10.1016/S0140-6736(13)62630-6

  57. Kulkarni PS, Desai S, Tewari T, Kawade A, Goyal N, Garg BS, et al. A randomized Phase III clinical trial to assess the efficacy of a bovinehuman reassortant pentavalent rotavirus vaccine in Indian infants. Vaccine. 2017;35(45):6228-37. https://doi.org/10.1016/j.vaccine.2017.09.014

  58. Isanaka S, Guindo O, Langendorf C, Matar-Seck A, Plikaytis BD, Sayinzoga-Makombe N, et al. Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger. N Engl J Med. 2017;376(12):1121-30. https://doi. org/10.1056/NEJMoa1609462




2020     |     www.medigraphic.com